ClinicalTrials.Veeva

Menu

Circulating microRNAs as Biomarkers of Sepsis

N

Naval Military Medical University

Status

Completed

Conditions

Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT00862290
microRNA_sepsis

Details and patient eligibility

About

MicroRNA has been demonstrated to play a crucial role in regulating cell processes. Recently, microRNA was identified to exist in human serum or plasma, and it might be related to certain diseases. Several microRNAs are involved in sepsis, such as miR-146, miR-155, and so on. But whether serum miR-146 is present in serum of septic patients remains unknown. The present study was designed to identify the existence of specific microRNAs, which might be new markers for sepsis and its prognosis.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients who develop sepsis and undergo abdominal surgery
  • patients who develop SIRS after cardiac surgery with cardiopulmonary bypass

Exclusion criteria

  • patients with a primary diagnosis of acute pancreatitis
  • patients with cirrhosis or renal dysfunction
  • patients with dyscrasia
  • patients with autoimmunity diseases
  • patients with severe cardiac and pulmonary diseases
  • patients with hematological diseases
  • patients who had organ dysfunction after cardiac surgery with cardiopulmonary bypass

Trial design

100 participants in 3 patient groups

sepsis group
Description:
Patients who develop sepsis in the ICU
SIRS group
Description:
Patients who develop SIRS after cardiac surgery with cardiopulmonary bypass
control group
Description:
normal healthy volunteers

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems